Canakinumab Fails to Improve Survival in Covid-19 Trial
Physician's Weekly,
CAN-COVID trial was designed, conducted early in…
CAN-COVID trial was designed, conducted early in…
An arthritis drug does not significantly increase the survival rate of a severe COVID-19 patient, a new study finds.